Tuberculosis and HIV infection: The global setting

Journal of Infectious Diseases

Volumn 196, Issue SUPPL. 1, 2007, Pages

  Nunn, Paul ^a,b   Reid, Alasdair ^c   De Cock, Kevin M ^b  

^a Stop TB Department ^*  (Switzerland)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c UNAIDS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COMMUNITY CARE; CONFERENCE PAPER; CONSENSUS; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; PRIORITY JOURNAL; SUPERINFECTION; TUBERCULOSIS;

FINANCIAL MANAGEMENT; HEALTH POLICY; HIV; HIV INFECTIONS; HUMANS; INTERNATIONAL COOPERATION; POLICY MAKING; TUBERCULOSIS; WORLD HEALTH;

EID: 34547628740     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/518660     Document Type: Conference Paper

References (68)

1. Pitchenik AE, Fischl MA. Disseminated tuberculosis and the acquired immunodeficiency syndrome. Ann Intern Med 1983; 98:112.
2. Mann J, Snider DE Jr, Francis H, et al. Association between HTLV-III/LAV infection and tuberculosis in Zaire [letter]. JAMA 1986; 256: 346.
3. Piot P, Quinn TC, Taelman H, et al. Acquired immunodeficiency syndrome in a heterosexual population in Zaire. Lancet 1984; 2:65-9.
4. Corbett EL, Marston B, Churchyard GJ, De Cock KM. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet 2006; 367:926-37.
5. Nunn P, Williams B, Floyd K, Dye C, Elzinga G, Raviglione M. Tuberculosis control in the era of HIV. Nat Rev Immunol 2005; 5:819-26.
6. Joint United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization. AIDS epidemic update: December 2006. Geneva: UNAIDS, 2006.
7. World Health Organization (WHO). Global tuberculosis control: surveillance, planning, financing. WHO report 2006. WHO/HTM/TB/2006.362. Geneva: WHO, 2006.
8. Joint United Nations Programme on HIV/AIDS (UNAIDS). AIDS epidemic update: December 2004. Geneva: UNAIDS, 2004.
9. Lucas SB, Hounnou A, Peacock C, et al. The mortality and pathology of HIV infection in a West African City. AIDS 1993; 7:1569-79.
10. Wallace D. The challenge of tuberculosis [correspondence]. Lancet 1995; 346:1162-3.
11. Riley DK, Babinchak TJ, Rotherams EB Jr. Tuberculosis: yesterday, today, and tomorrow [correspondence]. Ann Intern Med 1996; 124: 455.
12. Murray CJL. World tuberculosis burden. Lancet 1990; 335:1043-4.
13. World Health Organization (WHO). Laboratory services in tuberculosis control. Part II: microscopy. 1st ed. Geneva: WHO, 1998.
14. Mitchison DA. Treatment of tuberculosis. The Mitchell Lecture 1979. J R Coll Physicians Lond 1980; 14:91-9.
15. Chin DP, Hopewell PC. Mycobacterial complication of HIV infection. Clin Chest Med 1996; 17:697-711.
16. Nunn P, Kibuga D, Gathua S, et al. Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis. Lancet 1991; 337:627-30.
17. Nunn P, Gathua S, Kibuga D, et al. The impact of HIV on resource utilization by patients with tuberculosis in a tertiary referral hospital, Nairobi, Kenya. Tuber Lung Dis 1993; 74:273-9.
18. Hawken M, Nunn P, Gathua S, et al. Increased recurrence of tuberculosis in HIV-1-infected patients in Kenya. Lancet 1993; 342:332-7.
19. Nunn P, Brindle R, Carpenter L, et al. Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya: analysis of early (6-month) mortality. Am Rev Respir Dis 1992; 146:849-54.
20. Elliott AM, Halwiindi B, Hayes RJ, et al. The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia. Trans R Soc Trop Med Hyg 1995; 89: 78-82.
21. Harries AD, Nyirenda T, Banerjee A, Salaniponi FM, Boeree MJ. Tuberculosis control in the face of the HIV epidemic. Tropical Doctor 1998; 28:243-5.
22. Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle 1991; 72:1-6.
23. Styblo K. Epidemiology of tuberculosis. 2nd ed. The Hague: Royal Netherlands Tuberculosis Association, 1991.
24. Styblo K. Overview and epidemiologic assessment of the current global tuberculosis situation with an emphasis on control in developing countries. Rev Infect Dis 1989; 11(Suppl 2):S339-46.
25. Murray CJL, De Jonghe E, Chum HJ, Nyangulu DS, Salomao A, Styblo K. Cost effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries. Lancet 1991; 338:1305-8.
26. World Bank. World Development Report 1993: investing in health. New York: Oxford University Press, 1993.
27. Brudney K, Dobkin J. Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis 1991; 144:745-9.
28. Centers for Disease Control and Prevention. Emerging infectious diseases. Tuberculosis morbidity - United States, 1992. MMWR Morb Mortal Wkly Rep 1993; 42:696.
29. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City - turning the tide. N Engl J Med 1995; 333:229-33.
30. Cantwell MF, Binkin NJ. Impact of HIV on tuberculosis in sub-Saharan Africa: a regional perspective. Int J Tuberc Lung Dis 1997; 1:205-14.
31. De Cock KM, Chaisson RE. Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection. Int J Tuberc Lung Dis 1999; 3:457-65.
32. Farmer P, Bayona J, Becerra M, et al. The dilemma of MDR-TB in the global era. Int J Tuberc Lung Dis 1998; 2:869-76.
33. China Tuberculosis Control Collaboration. The effect of tuberculosis control in China. Lancet 2004; 364:417-22.
34. Suarez PG, Watt CJ, Alarcon E, et al. The dynamics of tuberculosis in response to 10 years of intensive control effort in Peru. J Infect Dis 2001; 184:473-8.
35. Ottmani S, Laasri L, Chaulet P, et al. La tuberculose et la lutte anti-tuberculeuse au Maroc de 1980 à 1998. DELM Bulletin Épidémiologique 1998; 35:2-12.
36. World Health Organization (WHO). Global tuberculosis control: surveillance, planning, financing. Geneva: WHO, 2005.
37. Raviglione M, Uplekar M. WHO's new Stop TB strategy. Lancet 2006; 367:952-5.
38. United Nations. 26th Special Session of the United Nations General Assembly, August 2001. Resolution A/RES/S-26/2. Available at: http://www.un.org/ga/aids/docs/aress262.pdf. Accessed 29 June 2007.
39. Marais H, Wilson A, eds. Report on the Global HIV/AIDS Epidemic. Geneva: Joint United Nations Programme on HIV/AIDS, 2002.
40. World Health Organization (WHO). Treating three million by 2005: making it happen. Geneva: WHO, 2003.
41. World Health Organization (WHO). Scaling up prevention and treatment for TB and HIV: report of the 4th Global TB/HIV Working Group Meeting. Geneva: WHO, 2004.
42. World Health Organization (WHO). Report of a "Lessons Learnt" Workshop on the six ProTEST pilot projects in Malawi, South Africa and Zambia. WHO/HTM/TB/2004.336. Geneva: WHO, 2004.
43. World Health Organization (WHO). A guide to monitoring and evaluation for collaborative TB/HIV activities: field test version. WHO/HTM/TB/2004.342; WHO/HIV/2004.09. Geneva: WHO, 2004.
44. World Health Organization (WHO). Interim policy on collaborative TB/HIV activities. WHO/HTM/TB/2004.330; WHO/HTM/HIV/2004.1. Geneva: WHO, 2004.
45. World Health Organization (WHO)/Stop TB Partnership. Actions for Life. Towards a world free of tuberculosis. The Global Plan to Stop Tuberculosis 2006-2015. WHO/HTM/STB/2006.35. Geneva: WHO, 2006.
46. United Nations. Millennium Development Goals. Available at: http://millenniumindicators.un.org/unsd/mi/mi_goals.asp. Accessed 14 April 2006.
47. G8. Chair's summary, Gleneagles Summit, 8th July. London, 2005. Available at: http://www.g8.gov.uk/servlet/Front?pagename=OpenMarket/Xcelerate/ ShowPage&c=Page&cid=1119518698846. Accessed 15 April 2006.
48. World Health Organization (WHO). Treating 3 million by 2005: making it happen. Geneva: WHO, 2003.
49. Joint United Nations Programme on HIV/AIDS (UNAIDS). Report on the global AIDS epidemic. Geneva: UNAIDS, 2004.
50. Joint United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization (WHO). UNAIDS/WHO policy statement on HIV testing. Available at: http://www.who.int/rpc/research_ethics/hivtestingpolicy_en_pdf.pdf. Accessed 5 July 2007.
51. World Health Organization (WHO). Progress on global access to HIV antiretroviral therapy: a report on "3 by 5" and beyond. Geneva: WHO, 2006.
52. Aylward RB, Linkins J. Polio eradication: mobilizing and managing the human resources. Bull World Health Organ 2005; 83:268-73.
53. Jack C, Lalloo U, Karim QA, et al. A pilot study of once-daily anti-retroviral therapy integrated with tuberculosis directly observed therapy in a resource-limited setting. J Acquir Immune Defic Syndr 2004; 36: 929-34.
54. Narasimhan V, Brown H, Pablos-Mendez A, et al. Responding to the global human resources crisis. Lancet 2004; 363:1469-72.
55. Chen L, Evans T, Anand S, et al. Human resources for health: overcoming the crisis. Lancet 2004; 364:1984-90.
56. Harries AD, Zachariah R, Bergstrom K, Blanc L, Salaniponi FM, Elzinga G. Human resources for control of tuberculosis and HIV-associated tuberculosis. Int J Tuberc Lung Dis 2005; 9:128-37.
57. Rigoli F, Dassault G. The interface between health sector reform and human resources in health. Hum Resour Health 2003; 1:1-12.
58. Harries AD, Nyirenda TE, Banerjee A, Mundy C, Salaniponi FM. District sputum smear microscopy services in Malawi. Int J Tuberc Lung Dis 1998; 2:914-8.
59. Elzinga G, Nunn P. TB and HIV: joint problems, joint solutions? Bull World Health Organ 2002; 80:469-70.
60. World Bank. An assessment of ongoing assistance: the Africa MAP. Committing to results: improving the effectiveness of HIV/AIDS Assistance. Washington, DC: The World Bank, 2004.
61. Commission for Africa. Our common interest: report of the Commission for Africa. London: Commission for Africa, 2005.
62. Zachariah R, Teck R, Ascurra O, et al. Can we get more HIV-positive tuberculosis patients on antiretroviral treatment in a rural district of Malawi? Int J Tuberc Lung Dis 2005; 9:238-47.
63. Coetzee D, Hilderbrand K, Goemaere E, Matthys F, Boelaert M. Integrating tuberculosis and HIV care in the primary care setting in South Africa. Trop Med Int Health 2004; 9:A11-5.
64. Weil DEC. Advancing tuberculosis control within reforming health systems. Int J Tuberc Lung Dis 2000; 4:597-605.
65. Bosman MCJ. Health sector reform and tuberculosis control: the case of Zambia. Int J Tuberc Lung Dis 2000; 4:606-14.
66. Maher D, van Gorkom JL, Gondrie PC, Raviglione M. Community contribution to tuberculosis care in countries with high tuberculosis prevalence: past, present and future. Int J Tuberc Lung Dis 1999; 3: 762-8.
67. Lonnroth K, Uplekar MW, Arora VK, et al. Public-private mix for DOTS implementation: what makes it work? Bull World Health Organ 2004; 82:580-6.
68. Conway S. Public-private mix for HIV (PPM-HIV). Technical approach papers. London: HLSP Institute, 2006.